Clinical Trial

C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-25
Trial Details
NCT Number NCT07527130
Lead Sponsor Mayo Clinic
Conditions COVID-19
Enrollment 10 participants
Start Date 2026-09
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-20